The Clinical and Medical Team at 89bio is responsible for designing and conducting clinical trials, ensuring regulatory compliance, and developing medical strategies for innovative therapies targeted at non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia. They oversee clinical operations, manage medical writing, analyze biostatistical data, and liaise with regulatory bodies to advance the company's drug development pipeline effectively and safely.
View all